Beruflich Dokumente
Kultur Dokumente
OF UROGENITAL
DISEASES
ARYANTI R. BAMAHRY
FK-UMI
2015
Kidney Function
Metabolic
Metabolic
End
EndProducts
Products
Bone
BoneStructure
Structure
Blood
BloodFormation
Formation
Calcium
Balance
Vitamin D
Activation
Erythropoietin
Synthesis
Removal of
Urea, Creatinine etc.
Water Balance
Potassium
Balance
Recovery of
Bicarbonate
Cardiac
CardiacActivity
Activity
Sodium
Removal
Regulation
RegulationofofBlood
BloodpH
pH
Blood
BloodPressure
Pressure
UROGENITAL DISEASES
Acute nephritis
Nephrotic syndrome
Asymptomatic urinary abnormalities
Acute renal failure
Chronic kidney disease
Urinary tract infection
Urinary tract obstruction
Nephrolithiasis
Hypertension
Renal tubular defects
NUTRITION SUPPORT IN
KIDNEY DISEASE
Energy
- 25-40 kcal/kgBW/d
- to avoid weight loss
Protein
- Renal disease proteinuria
- Uremia
restricting protein intake
Lipids
- Aggressively lowering lipids profile (?)
Fluids and electrolytes
- Water (500-600 ml +Urine Output)
- Sodium (1-3g/day)
- Potassium Hyperkalemia (!)
- Phosporus, calsium, magnesium
Vitamins
- poor oral intake
- decrease renal reabsorption
- losses from dialysis
Trace elements
- iron deficiency (poor oral intake/intestinal
absorption ERYTROPOIETIN
NEPHROTIC SYNDROME
An abnormal condition that is marked by deficiency of
albumin in the blood and its excretion in the urine due
to altered permeability of the glomerular basement
membranes.
CLINICAL SYMPTOMS :
NUTRITION THERAPY
GOAL :
Minimizing the effects of edema, proteinuria
& hyperlipidemia.
Replacing nutrients lost in the urine.
Reducing the risks of further renal
progression and atherosclerosis.
ARF
Gangguan Metabolisme
Regulasi tekanan darah
Ekskresi sisa metabolisme
Keseimbangan elektrolit
Regulasi hormonal
Akumulasi air
Elektrolit
Toksin uremi
ARF
Penurunan
ekskresi
Infeksi danfungsi
penyembuhan
Peningkatan produksi
dan penurunan klirens
Sisa metabolisme
Sitokin
Protease & hormon katabolik
Gangguan transport oksigen
dan nutrien
Akumulasi air
Elektrolit
Toksin uremi
Asidosis metabolik
Perubahan respon
glikemik
Glikogenolisis
Glukoneogenesis
Lipolisis
metabolisme Glukosa
resistensi insulin
hormon "antiinsulin"
HIPERKATABOLISME
Glukagon
Katekolamin
Glukokortikoid
HIPERKATABOLISME
Gangguan Imunitas
Daya Tahan tubuh
Katabolisme protein
keseimbangan nitrogen (-)
Infeksi
Survival Rate
Essential AA
Non-essential AA
Special AA
BCAA
valine
leucine
isoleucine
threonine
lysine
serine
decrease
production
oxidation in
muscles
metabolic
acidosis
glycine
citruline
cystine
aspartate
methionine
methylhistidine
KIDNEY
FAILURE
defective
phenylalanine
hydroxylation
tyrosine
tryptophane
arginine
reduce
protein binding
Energy
25-30 (max 35) kkal/kg BW/d
Carbohydrate
3-5 (max 7) g/kg BW/d
Lipid
0,8-1,2 (max 1,5) g/kg BW/d
Protein
Conservatif therapy
0,6-0,8 (max 1,0) g/kg BW/d
Extracorporeal therapy 1,0-1,5 g/kgBW/d
+ hyperkatabolism
max 1,7 g/kg BW/d
Vitamin
Requirement Water soluble vitamin increased
because of losses associated with renal replacement
therapy. (Vit. B6 10 mg/d, Vit. C 60-100 mg/d)
Fat soluble vitamin not lost during renal
replacement therapy supplementation not recommended
Electrolytes
Vary profoundly must be determined individually
Many patients ARF with hypokalemia/hypofosfatemia or during
CRRT with low electrolytes solutions.
Subjective Global
Assessment (SGA)
Fiaccadori, J Nephrol 2008;21:645-656
25
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the
Evaluation and Management of Chronic Kidney Disease. 2013
RISK FACTORS :
Diabetes
Hypertension
Autoimmune diseases
Systemic infections
Exposure to drugs or procedures associated with acute
decline in kidney function
Recovery from acute kidney failure
Age > 60 years
Family history of kidney disease
Reduced kidney mass (includes kidney donors and
transplant recipients)
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the
Evaluation and Management of Chronic Kidney Disease. 2013
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the
Evaluation and Management of Chronic Kidney Disease. 2013
CLINICAL SYMPTOMS
Edema
Uremia
Hyperphosphatemia
Hyperkalemia
Metabolic acidosis
Azotemia
Oliguria
Hypertension
Anemia
Bone & mineral disorders
Gastrointestinal symptoms
Dermatological changes
35
1.
CONSERVATIF MANAGEMENT
2.
DIALYSIS
A. HEMODIALISIS
B. PERITONEAL-DIALISIS
3.
TRANSPLANT
CONSERVATIF MANAGEMENT
1. LIMITATION SYMPTOMS
2. PREVENT IRREVERSIBLE RENAL
DAMAGED
3. MAINTAIN OF HEALTH BEFORE
DIALYSIS OR TRANSPLANTASION
36
NUTRITION THERAPY
GOAL :
To prevent malnutrition at an early stage of renal
disease/ maintain optimal nutritional status.
To reduce or control accumulation of waste products.
To prevent CVD disease by treating hyperlipidemia,
manage bone disease by treating vitamin D
deficiensies, and treating hyperparathyroidism.
To correct renal anemia to retard progression of renal
dysfunction.
NUTRITION THERAPY
1. Improve symptoms
2. Maintains a good nutritional state
3. Limits proteinuria
4. Can delay the time until renal replacement therapy is
needed.
2. Creatinine clearance
GFR renal damaged low creatinin clearance, creatinine
serum high
3. BUN (BLOOD UREA NITROGEN) indicator of renal function
Stabil PROTEIN DIET
BUN increased increased PROTEIN INTAKE.
Dehidration / catabolic state (surgery, burn, infection, fracture
drug catabolic: steroid
LEVEL 60- 80 mg/dl ACCEPTABLE
> 80
uremia
< 40
malnutrisi
4. Urea clearance filtration capability
NUTRITION THERAPY
(CKD-HD)
TUJUAN :
Mencegah, mendeteksi atau mengatasi
malnutrisi.
Mengurangi akumulasi cairan, sisa metabolisme,
kalium dan fosfor.
Mencegah komplikasi uremia (penyakit
kardiovaskuler dan penyakit tulang).
REKOMENDASI ASUPAN
VITAMIN LARUT AIR PADA CKD
Nutrien
Pre-Dialisis
Hemodialisis
Thiamine (B1)
1-1,5 mg/hari
1,1-1,2 mg/hari
Riboflavin (B2)
1-2 mg/hari
1,1-1,3 mg/hari
Niasin
Tidak ada
14-16 mg/hari
Tidak ada
5 mg/hari
Pyridoxine (B6)
5 mg/hari
10 mg/hari
Biotin
Tidak ada
30 g/hari
200 g/hari
1 mg/hari
Cobalamin (B12)
Tidak ada
2,4 g/hari
Suplementasi untuk
meningkatkan
absorpsi Fe
75-90 mg/hari
Vitamin C
REKOMENDASI ASUPAN
VITAMIN LARUT LEMAK PADA
CKD
Nutrien
Pre-Dialisis
Hemodialisis
Vitamin A
Tidak ada
700-900 g/hari
Vitamin D
Individual
Vitamin E
Tidak ada
400-800 IU/hari
Vitamin K
Tidak ada
90-120 g/hari
750-1000 mL/hari +
produksi urine
Cairan
Pre-Dialisis
Hemodialisis
< 5 g/hari
5-6 g/hari
Kalium
39 mg/kg/hari
tergantung nilai
laboratorium
8-17 mg/kg/hari
Kalsium
1200 mg/hari
800-1000 mg/hari
Zinc (Zn)
Tidak ada
Jika perlu
Besi (Fe)
Individual
Individual
Selenium
Tidak ada
Tidak ada
NaCl
Fosfor
NUTRITION MANAGEMENT ON
RENAL TRANSPLANTASION
1. Adequate food
2. CHO 40 50 % from total calories
3. Protein 1.2- 1.5 gr ADJUST TO NORMAL LEVEL
(Lab and electrolyte balance)
4. LIMITATION OF Na+ 2 - 4 gr / day
5. K+ as needed
49
KIDNEY STONES
RISK FACTORS
Family history
Hypercalciuria
Hyperuricosuria
Hyperoxaluria
Low urine volume
Gout
Excess intake of vitamin D
Urinary tract infections
Urinary tract blockages
CLINICAL SYMPTOMS
Kidney stones cause pain when they pass
down the ureters to the bladder and urethra
Hematuria
Pain with urination
Urgency to urinate
KIDNEY STONES
A. ENVIRONMENTAL FACTOR
1. CALSIUM ( 96%)
N eksresi 100 175 mg
Hipersecresion : high intake Ca, high vit.D
Long imobilisasion, hiperparathyroid
Renal tubular asidosis, high calsiurie
idiopatik
Dietary factors :
- Increased risk (animal protein, oxalate,
sodium )
- Decreased risk (Ca, K, Mg, fluid intake)
2. CYSTEIN ( herediter )
Homozygous cystinuria
3. Urid acid
End product of purin metabolism
4. Struvite
Magnesium, ammonium phosphate,
carbonate apatite Triple phosphate or
Infection stones
B. TRACTUS UROGENITAL
Changed of urine physically
Changed of urine concentration
Changed of urine balanced
RECURRENT INFECTION
DEFICIENCY OF VITAMIN A
( DESQUAMATION OF CEL EPITHEL)
DOT CALCIFICATION
RANDALLS PLAQUE
CALCIUM STONES
70-80% of kidney stones are composed of calcium
oxalate.
Almost half result from genetic predisposition.
Other causes:
Excess calcium in blood (hypercalcemia) or urine
(hypercalciuria)
Excess oxalate in urine (hyperoxaluria)
Low levels of citrate in urine (hypocitraturia)
Infection
EXAMPLES OF FOOD
SOURCES OF OXALATES
Fruits: berries, Concord grapes,
currants, figs, fruit cocktail, plums,
rhubarb, tangerines
Vegetables: baked/green/wax beans,
beet/collard greens, beets, celery, Swiss
chard, chives, eggplant, endive, kale,
okra, green peppers, spinach, sweet
potatoes, tomatoes
Nuts: almonds, cashews,
peanuts/peanut butter
Beverages: cocoa, draft beer, tea
Other: grits, tofu, wheat germ
STRUVITE STONES
Composed of magnesium ammonium
phosphate
Mainly caused by urinary tract infections
rather than specific nutrient
No diet therapy is involved
Usually removed surgically
OTHER STONES
Cystine stones
Caused by genetic metabolic defect
Occur rarely
Xanthine stones
Associated with treatment for gout and family
history of gout
Occur rarely
VARIATION DIET
1. LOW CALCIUM HIGH ASH ACID
2. HIGH DIET ASH ALKALIS
3. LOW PURINE DIET
68
MILK ???
NUTRITION THERAPY:
CALCIUM STONES
Low-calcium (?) diet (approx. 800mg/day)
recommended for those with
supersaturation of calcium in the urine and
who are not at risk for bone loss
If stone is calcium phosphate, sources of
phosphorus (meats, legumes, nuts) are
controlled
Fluid intake increased
Sodium intake decreased
Fiber foods high in phytates increased
LOW-CALCIUM DIET
NUTRITION THERAPY:
URIC ACID STONES
Low-purine diet sometimes recommended
Avoid:
Organ meats
Alcohol
Anchovies, sardines
Yeast
Legumes, mushrooms, spinach, asparagus,
cauliflower
Poultry
NUTRITION THERAPY:
CYSTINE STONES
Low-methionine diet (essentially a lowprotein diet) sometimes recommended
In children, a regular diet to support
growth is recommended
Medical drug therapy is used to control
infection or produce more alkaline urine
GENERAL MEASURES
TO PREVENT RECURRENT STONE FORMATION
Increase fluid intake to maintain urine output of 2-3 L/d:
increase in urine sodium as a result of increased
sodium intake. (Higher fluid intake alone will not prevent
recurrent stones in patients with hypercalciuria)
Decrease intake of animal protein ( 52 g/day):
Reduces production of metabolic acids, resulting in
a lower level of acid induced calcium excretion;
increases excretion of citrate that forms a soluble
complex with calcium; and reduces supersaturation with
respect to calcium oxalate and limits the excretion of
uric acid
THANK YOU